Operating Expenses 更改
Bioline Rx USD 9.91M 1.06M 2023-06
Insmed USD 261.96M 35.22M 2023-12
Nektar Therapeutics USD 69.01M 2.09M 2023-09
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06



Iveric bio 营业费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.